Mark Ma

418 total citations
18 papers, 309 citations indexed

About

Mark Ma is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark Ma has authored 18 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark Ma's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Biosimilars and Bioanalytical Methods (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Mark Ma is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Biosimilars and Bioanalytical Methods (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Mark Ma collaborates with scholars based in United States, Switzerland and Spain. Mark Ma's co-authors include Juan José Pérez Ruixo, Mark J. Rose, Andrew Chow, Sameer Doshi, Mark Peterson, Liviawati Sutjandra, Graham Jang, Wojciech Krzyżański, Yuling Wu and Yow‐Ming Wang and has published in prestigious journals such as Blood, Cancer Research and Analytical Biochemistry.

In The Last Decade

Mark Ma

18 papers receiving 288 citations

Peers

Mark Ma

ONCOL

RNMI

IMMUN

HEMAT

Xinfeng Yan China

J Michon France

Megumi Morimoto Japan

Ludovica Taglieri Italy

A. Nichols United States

Marike H. Dijkstra Finland

Guocan Yang China

Tammy L. Palenski United States

Jayna J. Mistry United Kingdom

Caroline S. Kim United States

Xinfeng Yan China

Mark Ma

177 ×1.1

83 ×1.1

ONCOL

27 ×0.5

RNMI

179 ×3.1

IMMUN

10 ×0.2

HEMAT

Citations per year, relative to Mark Ma Mark Ma (= 1×) peers Xinfeng Yan

Countries citing papers authored by Mark Ma

Since Specialization

Citations

This map shows the geographic impact of Mark Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ma more than expected).

Fields of papers citing papers by Mark Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ma. The network helps show where Mark Ma may publish in the future.

Co-authorship network of co-authors of Mark Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ma. A scholar is included among the top collaborators of Mark Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ma. Mark Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bittrich, Sebastian, Alexander Rose, David Sehnal, et al.. (2025). Visualizing and analyzing 3D biomolecular structures using Mol* at RCSB.org: Influenza A H5N1 virus proteome case study. Protein Science. 34(4). e70093–e70093. 1 indexed citations

Ma, Mark. (2024). Long-Acting Anti-Matriptase-2 Antibody As a Potentially Best-in-Class Therapy for Iron Overload Diseases. Blood. 144(Supplement 1). 3854–3854. 1 indexed citations

Martín‐Pérez, Mar, Alexander Michel, Mark Ma, & Luis A. Garcı́a Rodrı́guez. (2019). Development of hypotension in patients newly diagnosed with heart failure in UK general practice: retrospective cohort and nested case–control analyses. BMJ Open. 9(7). e028750–e028750. 7 indexed citations

Ma, Mark, Kelly Colletti, Tong‐Yuan Yang, et al.. (2019). Bioanalytical Challenges and Unique Considerations to Support Pharmacokinetic Characterization of Bispecific Biotherapeutics. Bioanalysis. 11(5). 427–435. 5 indexed citations

Ma, Mark, et al.. (2018). A Gyrolab Assay for the Quantitation of Free Complement Protein C5a in Human Plasma. The AAPS Journal. 20(6). 106–106. 9 indexed citations

Li, Ming, Yijin Xiao, Mark Ma, et al.. (2018). Development and validation of an LC–MS/MS Method for the quantitation of heparan sulfate in human urine. Biomedical Chromatography. 32(10). e4294–e4294. 4 indexed citations

Cao, Liangxian, Arthur Branstrom, John D. Baird, et al.. (2017). PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells. Blood. 130. 1371–1371. 1 indexed citations

Thom, Stephen R., et al.. (2017). Oxidative stress mediated by nitrogen at elevated pressure inhibits non-small cell lung cancer growth. Experimental Lung Research. 43(4-5). 175–180. 2 indexed citations

Ma, Mark, et al.. (2017). Challenges and Opportunities in Bioanalytical Support for Gene Therapy Medicinal Product Development. Bioanalysis. 9(18). 1423–1430. 7 indexed citations

10.

Wu, Benjamin, Erik Rasmussen, Lei Zhou, et al.. (2015). Pharmacokinetic drug–drug interaction assessment of peptibody trebananib in combination with chemotherapies. Cancer Chemotherapy and Pharmacology. 76(2). 243–250. 1 indexed citations

11.

Salimi-Moosavi, Hossein, et al.. (2014). A multifactorial screening strategy to identify anti-idiotypic reagents for bioanalytical support of antibody therapeutics. Analytical Biochemistry. 470. 52–60. 5 indexed citations

12.

Sutjandra, Liviawati, Sameer Doshi, Mark Ma, et al.. (2011). Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis. Clinical Pharmacokinetics. 50(12). 793–807. 87 indexed citations

13.

Xiao, Jim, Wojciech Krzyżański, Yow‐Ming Wang, et al.. (2010). Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys. The AAPS Journal. 12(4). 646–657. 68 indexed citations

14.

Chang, Li‐Ling, et al.. (2010). Co-possession of phosphodiesterase type-5 inhibitors (PDE5-I) with nitrates. Current Medical Research and Opinion. 26(6). 1451–1459. 5 indexed citations

15.

Coxon, Angela, Karen Rex, Jan Sun, et al.. (2008). Exploratory biomarkers in the HGF/SF:c-Met axis: preclinical and clinical results. Cancer Research. 68. 2804–2804. 2 indexed citations

16.

Miranda, Les P., Katherine A. Winters, Colin V. Gegg, et al.. (2008). Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity. Journal of Medicinal Chemistry. 51(9). 2758–2765. 71 indexed citations

17.

Kakkar, Tarundeep, et al.. (2007). Pharmacokinetics and Safety of a Fully Human Hepatocyte Growth Factor Antibody, AMG 102, in Cynomolgus Monkeys. Pharmaceutical Research. 24(10). 1910–1918. 31 indexed citations

18.

Li, Biao, et al.. (2003). Simian retrovirus serogroup 2 constitutive transport element recognizes the ribosomal L10-like protein and translocon gamma subunit-like protein in a yeast three-hybrid assay. Virus Research. 99(1). 69–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact